Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors
Clinical trial NCT04349267 · COMPLETED
Trial details
- NCT number
- NCT04349267
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-14
- Primary completion
- 2024-08-22
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.